# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

> **NCT00003652** · PHASE3 · COMPLETED · sponsor: **UNICANCER** · enrollment: 350 (estimated)

## Conditions studied

- Anal Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **PROCEDURE:** neoadjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003652
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01-04
- **Primary completion:** 2006-04-01
- **Final completion:** 2007-03-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2021-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003652, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00003652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*